retatrutide nonalcoholic steatohepatitis trial Results: 28.3% Weight Loss Data MASH Treatment: Curcumin Shows Promising
Description
This likely reflects dose differences rather than efficacy differences, but it definitively disproves the myth that diabetes is required for weight loss response
Heloderma suspectum venom with 53% homology to mammalian GLP-1, and can resist DPP-4 degradation and has low renal clearance rate (Muttenthaler et al., 2021)
Many people describe this phase as a gentle introduction rather than a dramatic change
Dermatologic outcomes: GLP-1 RA versus DPP-4i use The mean follow-up duration was 1,080 454 days in the GLP-1 RA group and 1,121 498 days in the DPP-4i group ( Supplementary Figure 1 )
